2015Journal of Clinical Pulmonary MedicineRequires access

Comparison of different doses intravenous injection of bleomycin-induced pulmonary fibrosis in mice

Qian Xiao

Open publisher page 0 citations

Abstract

Objective To establish a mouse model of pulmonary fibrosis by using an improved program.Methods C57 / BL6 male mice were randomly divided into the single-dose group and the multiple-dose group. The single-dose group were randomly divided into the groups of 100,150,200 mg / kg and the control group 1. The multiple-dose group were randomly divided into the 50 mg / kg group and the control group 2. Their pathology of each lungs,immunohistochemistry of Col-Ⅰ,TGF-β1 and α-SMA were analyzed. Results The level of alveolitis reached the highest point at the second week in the single-dose group( P 0. 01),and the level of pulmonary fibrosis reached the highest at the second and fourth weeks,respectively( P 0. 01). In the 50 mg / kg group,the levels of alveolitis and fibrosis peaked at the 10 th week( P 0. 05). TGF-β1 and α-SMA increased significantly in parts of alveolitis and pulmonary fibrosis. Conclusion In an intravenous delivery,a single dose of 200 mg / kg bleomycin can effectively reproduce pulmonary fibrosis.

About this research paper

What this paper is about

Objective To establish a mouse model of pulmonary fibrosis by using an improved program.Methods C57 / BL6 male mice were randomly divided into the single-dose group and the multiple-dose group. The single-dose group were randomly divided into the groups of 100,150,200 mg / kg and the control group 1. The multiple-dose group were randomly divided into the 50 mg / kg group and the control group 2. Their pathology of each lungs,immunohistochemistry of Col-Ⅰ,TGF-β1 and α-SMA were analyzed. Results The level of alveolitis reached the highest point at the second week in the single-dose group( P 0. 01),and the level of pulmonary fibrosis reached the highest at the second and fourth weeks,respectively( P 0. 01). In the 50 mg / kg group,the levels of alveolitis and fibrosis peaked at the 10 th week( P 0. 05). TGF-β1 and α-SMA increased significantly in parts of alveolitis and pulmonary fibrosis. Conclusion In an intravenous delivery,a single dose of 200 mg / kg bleomycin can effectively reproduce pulmonary fibrosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To establish a mouse model of pulmonary fibrosis by using an improved program.Methods C57 / BL6 male mice were randomly divided into the single-dose group and the multiple-dose group. The single-dose group were randomly divided into the groups of 100,150,200 mg / kg and the control group 1. The multiple-dose group were randomly divided into the 50 mg / kg group and the control group 2. Their pathology of each lungs,immunohistochemistry of Col-Ⅰ,TGF-β1 and α-SMA were analyzed. Results The level of alveolitis reached the highest point at the second week in the single-dose group( P 0. 01),and the level of pulmonary fibrosis reached the highest at the second and fourth weeks,respectively( P 0. 01). In the 50 mg / kg group,the levels of alveolitis and fibrosis peaked at the 10 th week( P 0. 05). TGF-β1 and α-SMA increased significantly in parts of alveolitis and pulmonary fibrosis. Conclusion In an intravenous delivery,a single dose of 200 mg / kg bleomycin can effectively reproduce pulmonary fibrosis.

Key concepts: Bleomycin, Medicine, Pulmonary fibrosis, Fibrosis, Lung, Immunohistochemistry, Gastroenterology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of different doses intravenous injection of bleomycin-induced pulmonary fibrosis in mice — Research Paper | ScholarLens